• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Denis Chem Lab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13342.0
  • ISIN : INE051G01012
70.70 0 (-0.20%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    70.21

  • Today’s High

    71.80

  • Open

    70.36

  • Perv Close

    70.84

  • 52W Low

    56.10

  • 52W High

    103.00

Key Indicators

  • P/E(TTM)

    12.30

  • Mar.Cap (₹Cr.)

    98.11

  • Div & Yield %

    3.54

  • Book Value(₹)

    65.99

  • Debt-Equity Ratio

    -0.20

  • AGM Date

    04-Sep-2026

  • EPS

    5.75

  • P/E Ratio

    12.30

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    98.11

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.88

  • BV (₹)

    66.00

  • Sales( ₹ in Cr.)

    181.72

  • NP (in Cr.)

    8.41

  • NP Var(%)

    4.0

  • Div%

    25.0

  • CPS (₹)

    11.00

  • EPS (₹)

    6.10

  • Traded Value (₹ in Lakhs)

    98.11

  • 52 Week High

    103.00

  • 52 Week Low

    56.10

  • Price BSE

    71.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    98.11

  • P/C Ratio

    6.50

  • P/E Ratio

    11.70

  • Price Vs.BV

    6.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 181.72 173.30 167.82 160.85 136.56 109.32
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 181.72 173.30 167.82 160.85 136.56 109.32
Other Income 1.92 2.37 1.39 0.59 1.05 0.35
Stock Adjustments 0.48 -0.68 1.01 -1.05 -0.03 0.36
Total Income 184.12 174.99 170.22 160.39 137.58 110.03
EXPENDITURE :            
Raw Materials 98.20 95.09 87.88 83.41 72.32 55.80
Power and Fuel Cost 10.15 9.96 10.59 10.02 8.73 7.22
Employee Cost 17.16 15.26 14.39 13.03 11.74 10.59
Other Manufacturing Expenses 4.40 4.74 4.52 4.88 3.27 2.85
Selling and Administration Expenses 30.60 28.69 26.46 24.99 22.79 19.20
Miscellaneous Expenses 4.04 2.77 3.76 4.70 3.33 3.77
Employee Benefit Expenses 17.16 15.26 14.39 13.03 11.74 10.59
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 164.56 156.51 147.61 141.02 122.18 99.43
Operating Profit 19.57 18.48 22.62 19.37 15.40 10.60
Interest 0.84 0.51 0.54 0.64 0.76 1.55
Gross Profit 18.73 17.97 22.08 18.73 14.64 9.05
Depreciation 6.84 6.86 6.95 7.82 5.76 5.96
Profit Before Tax 11.89 11.11 15.13 10.91 8.88 3.09
Current Tax 3.85 3.93 4.87 3.65 2.15 1.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.37 -0.90 -0.89 -0.60 0.47 -0.34
Reported Net Profit 8.41 8.08 11.16 7.86 6.26 2.26
Extraordinary Items 0.00 0.00 0.00 0.00 0.02 0.00
Adjusted Net Profit 8.41 8.08 11.16 7.86 6.24 2.26
Adjustment below Net Profit 0.14 0.13 -0.28 0.03 -0.28 0.15
P & L Balance brought forward 39.03 34.29 26.19 20.38 15.43 13.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.08 3.47 2.78 2.08 1.04 0.00
P & L Balance carried down 45.50 39.03 34.29 26.19 20.38 15.43
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 15.00 25.00 20.00 15.00 7.50
Dividend Per Share(Rs) 2.50 1.50 2.50 2.00 1.50 0.75
Earnings Per Share-Unit Curr 6.06 5.82 8.04 5.66 4.51 1.63
Earnings Per Share(Adj)-Unit Curr 6.06 5.82 8.04 5.66 4.51 1.63
Book Value 65.99 61.33 57.91 52.08 47.89 44.32
Book Value(Adj)-Unit Curr 65.99 61.33 57.91 52.08 47.89 44.32

Shareholding Pattern

  • Promoter Group

    38.98%

  • Public Share Holding

    61.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,409,237 38.98 5,409,237 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,409,237 38.98 5,409,237 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,000 0.01 1,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,000 0.01 1,000 1
2] Non Institution
Bodies Corporate 1,232,202 8.88 1,232,202 21
Clearing Members 237 0.00 237 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 67,882 0.49 67,682 99
Foreign Non Institution Other 2,877,774 20.74 2,877,774 1
Hindu Undivided Families 192,075 1.38 192,075 194
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,498,795 10.80 1,498,795 8
Individuals holding nominal share capital up to Rs. 1 lakh 2,592,181 18.68 2,385,514 6,476
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 274 0.00 224 2
Sub Total 8,466,431 61.01 8,259,514 6,807
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,876,668 100.00 13,669,751 6,811

Company Background

Denis Chem Lab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Denis Chem Lab Ltd
  • BSE Code : 13342.0
  • ISIN : INE051G01012

  • Incorporation Year

    1980

  • Registered Office

    Block No 457 Kalol Taluka
    Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-2764-233596/233613

  • FAX

    91-2764-233896

  • Chairman

    Dinesh B Patel

  • Managing Director

  • Company Secretary

    Anal Ruchir Desai

  • Auditor

    Shah & Shah Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Denis Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Denis Chem Lab 70.70 183.64 181.72 12.30 13.90
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77